Antibodies, B cells, and immune tolerance in immunotherapy treated oesophageal cancer
Oesophageal cancer (OC) is a leading cause of cancer mortality that is rapidly rising in prevalence in many parts of the world. Immune checkpoint inhibitors (ICI) have revolutionised treatment of many cancer types and were recently approved by the FDA to treat advanced OC. However, there are still m...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
2022
|
| Subjects: |